ALGN Quote, Financials, Valuation and Earnings

Envista Holdings has a net margin of 10.43% compared to Align Technology's net margin of 0.18%. Align Technology's return on equity of 11.12% beat Envista Holdings's return on equity of -32.33%.

Align Technology has a consensus price target of $254.64, signalling upside risk potential of 53.21%. On the other hand Envista Holdings has an analysts' consensus of $21.33 which suggests that it could grow by 28.13%. Given that Align Technology has higher upside potential than Envista Holdings, analysts believe Align Technology is more attractive than Envista Holdings.

Align Technology has a beta of 1.687, which suggesting that the stock is 68.738% more volatile than S&P 500. In comparison Envista Holdings has a beta of 1.326, suggesting its more volatile than the S&P 500 by 32.59%.

Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

Align Technology quarterly revenues are $995.2M, which are larger than Envista Holdings quarterly revenues of $652.9M. Align Technology's net income of $103.8M is higher than Envista Holdings's net income of $1.2M. Notably, Align Technology's price-to-earnings ratio is 29.63x while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.12x versus 1.15x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

ResMed has a net margin of 10.43% compared to Align Technology's net margin of 26.88%. Align Technology's return on equity of 11.12% beat ResMed's return on equity of 25.56%.

Align Technology has a consensus price target of $254.64, signalling upside risk potential of 53.21%. On the other hand ResMed has an analysts' consensus of $269.38 which suggests that it could grow by 20.17%. Given that Align Technology has higher upside potential than ResMed, analysts believe Align Technology is more attractive than ResMed.

Align Technology has a beta of 1.687, which suggesting that the stock is 68.738% more volatile than S&P 500. In comparison ResMed has a beta of 0.738, suggesting its less volatile than the S&P 500 by 26.22%.

Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ResMed offers a yield of 0.92% to investors and pays a quarterly dividend of $0.53 per share. Align Technology pays -- of its earnings as a dividend. ResMed pays out 27.65% of its earnings as a dividend. ResMed's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Align Technology quarterly revenues are $995.2M, which are smaller than ResMed quarterly revenues of $1.3B. Align Technology's net income of $103.8M is lower than ResMed's net income of $344.6M. Notably, Align Technology's price-to-earnings ratio is 29.63x while ResMed's PE ratio is 26.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.12x versus 6.71x for ResMed. Usually stocks with elevated PS ratios are considered overvalued.

Steris PLC has a net margin of 10.43% compared to Align Technology's net margin of 12.66%. Align Technology's return on equity of 11.12% beat Steris PLC's return on equity of 7.27%.

Align Technology has a consensus price target of $254.64, signalling upside risk potential of 53.21%. On the other hand Steris PLC has an analysts' consensus of $250.13 which suggests that it could grow by 10.37%. Given that Align Technology has higher upside potential than Steris PLC, analysts believe Align Technology is more attractive than Steris PLC.

Align Technology has a beta of 1.687, which suggesting that the stock is 68.738% more volatile than S&P 500. In comparison Steris PLC has a beta of 0.919, suggesting its less volatile than the S&P 500 by 8.088%.

Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Steris PLC offers a yield of 0.98% to investors and pays a quarterly dividend of $0.57 per share. Align Technology pays -- of its earnings as a dividend. Steris PLC pays out 53.03% of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Align Technology quarterly revenues are $995.2M, which are smaller than Steris PLC quarterly revenues of $1.4B. Align Technology's net income of $103.8M is lower than Steris PLC's net income of $173.5M. Notably, Align Technology's price-to-earnings ratio is 29.63x while Steris PLC's PE ratio is 48.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.12x versus 4.17x for Steris PLC. Usually stocks with elevated PS ratios are considered overvalued.

Dentsply Sirona has a net margin of 10.43% compared to Align Technology's net margin of -47.51%. Align Technology's return on equity of 11.12% beat Dentsply Sirona's return on equity of -32.39%.

Align Technology has a consensus price target of $254.64, signalling upside risk potential of 53.21%. On the other hand Dentsply Sirona has an analysts' consensus of $20.20 which suggests that it could grow by 31.77%. Given that Align Technology has higher upside potential than Dentsply Sirona, analysts believe Align Technology is more attractive than Dentsply Sirona.

Align Technology has a beta of 1.687, which suggesting that the stock is 68.738% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.383%.

Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 4.18% to investors and pays a quarterly dividend of $0.16 per share. Align Technology pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.

Align Technology quarterly revenues are $995.2M, which are larger than Dentsply Sirona quarterly revenues of $905M. Align Technology's net income of $103.8M is higher than Dentsply Sirona's net income of -$430M. Notably, Align Technology's price-to-earnings ratio is 29.63x while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.12x versus 0.82x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.